Search research articles
Contact Us
Filters
Showing results (151-160 of 165) with videos related to
Page
of 17
Sort By:
Prostate Cancer and Prostatic Diseases
|
December 14, 2018
Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population
Gyorgy Petrovics, Douglas K Price, Hong Lou, et al.
Australian Journal of General Practice
|
February 8, 2026
A summary of the first Australian and Aotearoa New Zealand Clinical Practice Guideline for the management of mild traumatic brain injury/concussion and persisting post-concussion symptoms
Rhonda Orr, Gary Browne, Gill Cowen, et al.
Journal of Translational Medicine
|
January 9, 2020
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer
Michael A Kiebish, Jennifer Cullen, Prachi Mishra, et al.
Cancers
|
May 21, 2020
Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression
Yuqian Gao, Yi-Ting Wang, Yongmei Chen, et al.
Nature Communications
|
March 16, 2022
Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes
Indu Kohaar, Xijun Zhang, Shyh-Han Tan, et al.
The Medical Journal of Australia
|
November 2, 2025
Mild traumatic brain injury and concussion and persisting post-concussion symptoms: new guidelines to support evidence-based assessment and management in Australia and Aotearoa New Zealand
Karen M Barlow, Jennie L Ponsford, Alice Theodom, et al.
Journal of the National Cancer Institute. Monographs
|
August 7, 2024
Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers
Gary L Ellison, Kathy J Helzlsouer, Sonia M Rosenfield, et al.
Journal of the National Cancer Institute
|
February 18, 2015
Leveraging biospecimen resources for discovery or validation of markers for early cancer detection
Sheri D Schully, Danielle M Carrick, Leah E Mechanic, et al.
Scientific Reports
|
July 24, 2021
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia
Michael A Kiebish, Poornima Tekumalla, Shobha Ravipaty, et al.
Prostate Cancer and Prostatic Diseases
|
June 15, 2021
Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24
Roshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 165) with videos related to
Sort By:
Page
of 17
Prostate Cancer and Prostatic Diseases
|
December 14, 2018
Increased frequency of germline BRCA2 mutations associates with prostate cancer metastasis in a racially diverse patient population
Gyorgy Petrovics, Douglas K Price, Hong Lou, et al.
Australian Journal of General Practice
|
February 8, 2026
A summary of the first Australian and Aotearoa New Zealand Clinical Practice Guideline for the management of mild traumatic brain injury/concussion and persisting post-concussion symptoms
Rhonda Orr, Gary Browne, Gill Cowen, et al.
Journal of Translational Medicine
|
January 9, 2020
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer
Michael A Kiebish, Jennifer Cullen, Prachi Mishra, et al.
Cancers
|
May 21, 2020
Proteomic Tissue-Based Classifier for Early Prediction of Prostate Cancer Progression
Yuqian Gao, Yi-Ting Wang, Yongmei Chen, et al.
Nature Communications
|
March 16, 2022
Germline mutation landscape of DNA damage repair genes in African Americans with prostate cancer highlights potentially targetable RAD genes
Indu Kohaar, Xijun Zhang, Shyh-Han Tan, et al.
The Medical Journal of Australia
|
November 2, 2025
Mild traumatic brain injury and concussion and persisting post-concussion symptoms: new guidelines to support evidence-based assessment and management in Australia and Aotearoa New Zealand
Karen M Barlow, Jennie L Ponsford, Alice Theodom, et al.
Journal of the National Cancer Institute. Monographs
|
August 7, 2024
Perceptions, prevalence, and patterns of cannabis use among cancer patients treated at 12 NCI-Designated Cancer Centers
Gary L Ellison, Kathy J Helzlsouer, Sonia M Rosenfield, et al.
Journal of the National Cancer Institute
|
February 18, 2015
Leveraging biospecimen resources for discovery or validation of markers for early cancer detection
Sheri D Schully, Danielle M Carrick, Leah E Mechanic, et al.
Scientific Reports
|
July 24, 2021
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia
Michael A Kiebish, Poornima Tekumalla, Shobha Ravipaty, et al.
Prostate Cancer and Prostatic Diseases
|
June 15, 2021
Performance of African-ancestry-specific polygenic hazard score varies according to local ancestry in 8q24
Roshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Page
of 17